Table 3 Essential correlations between CD44 cell-surface glycoprotein expression and histoclinical features
Characteristics | Specimens No (%) | Immunohistochimical expression of CD44 protein | P value | |
|---|---|---|---|---|
Negative (%) | Positive (%) | |||
Age (months) | ||||
< 18 | 11 (34.4) | 5 (45.5) | 6 (54.5) | 1* |
≥ 18 | 21 (65.6) | 9 (42.9) | 12 (57.1) | |
Primary site | ||||
Retroperitoneal space | 22 (71) | 9 (40.9) | 13 (59.1) | 1* |
Other sites | 9 (29) | 4 (44.4) | 5 (55.6) | |
Metastasis | ||||
Presence | 21 (65.6) | 13 (61.9) | 8 (38.1) | 0.013* |
Absence | 11 (34.4) | 1 (9.1) | 10 (90.9) | |
INSS stages | ||||
I, II, IVs | 9 (28.1) | 0 (0.0) | 9 (100.0) | 0.006 |
III, IV | 23 (71.9) | 14 (60.9) | 9 (39,1) | |
Differentiation | ||||
NB | 18 (56.2) | 11 (61.1) | 7 (38.9) | 0.025 |
GNB + GN | 14 (43.8) | 3 (21.4) | 11 (78.6) | |
Shimada category | ||||
FH | 13 (40,6) | 1 (7.7) | 12 (92.3) | 0.001 |
UH | 19 (59,4) | 13 (68.4) | 6 (31.6) | |